The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
News
Services
Subscribe
Advertise
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Rights & permissions
Contact us
Author centre
Ron Waksman
Showing 1-20 of 41 articles
Lipid-rich plaque density and low-density lipoprotein cholesterol in statin-treated versus statin-naïve patients: a post hoc analysis of the LRP study
Torguson R,
Mintz G,
Zhang C,
Case B,
Di Mario C,
Garcia-Garcia H,
Waksman R
May 15, 2022 | 10.4244/EIJ-D-21-00701
Lifetime management of patients with symptomatic severe aortic stenosis: a computed tomography simulation study
Medranda GA,
Soria Jimenez CE,
Torguson R,
Case B,
Forrestal BJ,
Ali SW,
Shea C,
Zhang C,
Wang JC,
Gordon P,
Ehsan A,
Wilson SR,
Levitt R,
Parikh P,
Bilfinger T,
Hanna N,
Buchbinder M,
Asch FM,
Weissman G,
Shults CC,
Garcia-Garcia H,
Ben-Dor I,
Satler LF,
Waksman R,
Rogers T
March 25, 2022 | 10.4244/EIJ-D-21-01091
Scaffold thrombosis: what is to blame?
Waksman R,
Bhogal S
December 17, 2021 | 10.4244/EIJV17I12A159
A prospective, multicentre first-in-man study of the polymer-free ultrathin-strut BIOrapid stent (BIOVITESSE)
Räber L,
Häner J,
Lüscher T,
Moccetti M,
Roffi M,
Stortecky S,
Muller O,
Garcia-Garcia H,
Waksman R,
Siegrist P
November 11, 2021 | 10.4244/EIJ-D-21-00537
High bleeding risk patients: one size does not fit all
Waksman R,
Yerasi C
June 25, 2021 | 10.4244/EIJV17I3A35
Entrapment of the Impella heart pump in the mitral subvalvular apparatus
Khalid N,
Shlofmitz E,
Case B,
Waksman R
February 5, 2021 | 10.4244/EIJ-D-19-00942
Adverse events with orbital atherectomy: an analytic review of the MAUDE database
Khalid N,
Javed H,
Rogers T,
Hashim H,
Shlofmitz E,
Wermers J,
Chen Y,
Musallam A,
Khan J,
Torguson R,
Bernardo N,
Waksman R
July 17, 2020 | 10.4244/EIJ-D-19-00295
Bioresorbable scaffolds: did we jump the gun?
Waksman R,
Forrestal B
June 12, 2020 | 10.4244/EIJV16I2A16
Safety and performance of the second-generation drug-eluting absorbable metal scaffold (DREAMS 2G) in patients with de novo coronary lesions: three-year clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial
Haude M,
Ince H,
Toelg R,
Lemos P,
von Birgelen C,
Christiansen E,
Wijns W,
Neumann F,
Eeckhout E,
Garcia-Garcia H,
Waksman R
February 7, 2020 | 10.4244/EIJ-D-18-01000
BIOFLOW-IV, a randomised, intercontinental, multicentre study to assess the safety and effectiveness of the Orsiro sirolimus-eluting stent in the treatment of subjects with de novo coronary artery lesions: primary outcome target vessel failure at 12 months
Saito S,
Toelg R,
Witzenbichler B,
Haude M,
Masotti M,
Salmeron R,
Witkowski A,
Uematsu M,
Takahashi A,
Waksman R,
Slagboom T
December 6, 2019 | 10.4244/EIJ-D-18-01214
Reply to the letter to the editor “Impella device use in high-risk PCI”
Khalid N,
Rogers T,
Shlofmitz E,
Chen Y,
Waksman R
October 18, 2019 | 10.4244/EIJ-D-19-00279R
Paclitaxel-coated balloons and stents for the treatment of peripheral artery disease: proceedings from the Cardiovascular Research Technologies (CRT) 2019 Town Hall
Dan K,
Garcia-Garcia H,
Hideo-Kajita A,
Zhang C,
Wermers J,
Kolm P,
Torguson R,
Waksman R
July 19, 2019 | 10.4244/EIJV15I4A59
Paclitaxel-coated balloons and stents for the treatment of peripheral artery disease: proceedings from the Cardiovascular Research Technologies (CRT) 2019 Town Hall
Dan K,
Garcia-Garcia H,
Hideo-Kajita A,
Zhang C,
Wermers J,
Kolm P,
Torguson R,
Waksman R
June 13, 2019 | 10.4244/EIJY19M06_1
Adverse events and modes of failure related to the Impella percutaneous left ventricular assist devices: a retrospective analysis of the MAUDE database
Khalid N,
Rogers T,
Shlofmitz E,
Chen Y,
Khan J,
Musallam A,
Iantorno M,
Waksman R
May 20, 2019 | 10.4244/EIJ-D-18-01021
Comparison of acute thrombogenicity for magnesium versus stainless steel stents in a porcine arteriovenous shunt model
Lipinski M,
Acampado E,
Cheng Q,
Adams L,
Torii S,
Gai J,
Torguson R,
Hellinga DG,
Joner M,
Harder C,
Zumstein P,
Finn A,
Kolodgie F,
Virmani R,
Waksman R
January 18, 2019 | 10.4244/EIJ-D-17-00958
Preclinical evaluation of degradation kinetics and elemental mapping of first- and second-generation bioresorbable magnesium scaffolds
Joner M,
Ruppelt P,
Zumstein P,
Lapointe-Corriveau C,
Leclerc G,
Bulin A,
Castellanos M,
Wittchow E,
Haude M,
Waksman R
October 12, 2018 | 10.4244/EIJ-D-17-00708
Sustained safety and clinical performance of a drug-eluting absorbable metal scaffold up to 24 months: pooled outcomes of BIOSOLVE-II and BIOSOLVE-III
Haude M,
Ince H,
Kische S,
Abizaid A,
Toelg R,
Lemos P,
Van Mieghem N,
Verheye S,
von Birgelen C,
Christiansen E,
Wijns W,
Garcia-Garcia H,
Waksman R
July 20, 2017 | 10.4244/EIJ-D-17-00254
Second-generation magnesium scaffold Magmaris: device design and preclinical evaluation in a porcine coronary artery model
Waksman R,
Zumstein P,
Pritsch M,
Wittchow E,
Haude M,
Lapointe-Corriveau C,
Leclerc G,
Joner M
July 20, 2017 | 10.4244/EIJ-D-16-00915
Does acute coronary syndrome impact on the incidence of thrombosis after the implantation of an Absorb bioresorbable vascular scaffold?
Sotomi Y,
Miyazaki Y,
Collet C,
Asano T,
Suwannasom P,
Thijssen J,
de Winter R,
Waksman R,
Lipinski M,
Onuma Y,
Serruys P
March 20, 2017 | 10.4244/EIJ-D-16-00472
Chipping of calcified plaques by orbital atherectomy systems, but holding approval tight: is the FDA moving faster than the European CE agency? A North American perspective
Waksman R,
Garcia-Garcia H
October 20, 2016 | 10.4244/EIJV12I9A178
1
2
3
Latest news
AHEAD OF PRINT
Catheter-directed thrombolysis in intermediate-high risk acute pulmonary embolism
FREE ARTICLE - Josef Kroupa et al
May 27, 2022
EUROPCR LATE BREAKING
EuroPCR 2022 Late-breaking publications: watch the interviews with the authors!
May 23, 2022
NEW ISSUE
TAVI vs SAVR for bicuspid anatomies; PVR and TAVI; LAA thrombus trapping; crush techniques for bifurcation PCIs; stent elongation in POT and more
May 18, 2022
AHEAD OF PRINT
Delayed hospitalisation in the MITRA-FR trial
FREE ARTICLE - Guillaume Leurent et al
May 25, 2022
AHEAD OF PRINT
Complete cerebral protection during TAVI
FREE ARTICLE - Dariusz Jagielak et al
May 24, 2022
AHEAD OF PRINT
Outcomes of PCI for stent thrombosis
FREE ARTICLE - Mohamed O. Mohamed et al
May 24, 2022
EUROPCR LATE BREAKING
Changes in voice patterns for monitoring heart failure deterioration
FREE ARTICLE - Chaim Lotan et al
May 24, 2022
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke